Halbert Hargrove Global Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$166K	Buy	+1,000	New	+$164K	0.01%	106

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Halbert Hargrove Global Advisors's LABU Position: Q1 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026: 1,000 shares worth $166K. The stake represents 0.01% of the portfolio and ranks #106 among its holdings.

33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

Halbert Hargrove Global Advisors held 1,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $166K as of Q1 2026.
Direxion Daily S&P Biotech Bull 3X ETF was a new Halbert Hargrove Global Advisors position in Q1 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.01% of Halbert Hargrove Global Advisors's portfolio in Q1 2026, its #106 holding.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.